Ajovy, Teva's migraine drug, recommended by UK's NICE.
Teva migraine medicine gets EU positive opinion
Teva's CGRP-Inhibitor Reduced Monthly Migraine Days in Late-Stage Trial | BioSpace
Teva and Eli Lilly scrap over migraine drug rights — MedWatch
Teva stops selling migraine patches after reports of burns | The Times of Israel
Teva and Heptares to develop treatments for migraine
Teva Pharmaceuticals on Twitter: "#Migraine is a prevalent disease! Learn more at Teva Medical Affairs booth 13 #IHC2017 https://t.co/UOYP8m1FM4" / Twitter
Teva Pharmaceuticals on Twitter: "Migraine is not just a headache. Our migraine expert, Dr Joshua Cohen, explains why it's time to break the stigma. #MigraineandHeadacheAwarenessMonth https://t.co/rD3hXiRVoc https://t.co/b46jYhpZSH" / Twitter
Teva files potential blockbuster migraine drug for FDA approval
Teva Announces Ministry of Health, Labour and Welfare Approves AJOVY® (fremanezumab) Injection in Japan for the Preventive Treatment of Migraine in Adults | Business Wire
Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Group
Teva tries to make something out of nothing with Ajovy approval | Evaluate
Boston Jury Awards Teva Pharmaceuticals $176.5M for Eli Lilly's Migraine Medication Patent Infringement | Law.com
Teva - Migraine World Summit
Teva's Migraine Treatment Effective In Patients With Co-Morbid Depression
Eli Lilly (NYSE:LLY) Loses Migraine Drug Patent Trial to Teva - TipRanks.com
Report: Teva Suffers Migraine Over Express Scripts Drug Exclusion - Pharmaceutical Processing World
Preventive Treatment of Migraine–AJOVY® (fremanezumab-vfrm) injection
Teva shares rally as FDA approves troubled drugmaker's migraine treatment | The Times of Israel
Teva's migraine med given marketing authorization
Teva notched a win in its migraine patent feud with Eli Lilly
The UK-Israeli Small-Molecule Offensive Against Migraines
